Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
22.01. | AFT Pharmaceuticals - Another R&D asset in the bag | 344 | Edison Investment Research | AFT Pharmaceuticals has announced the addition of another candidate, HY-091, to its R&D pipeline, for the management of vulvar lichen sclerosus (VLS), a skin condition with no curative treatments available.... ► Artikel lesen | |
22.01. | Accsys Technologies - Updating estimates for guidance and capital raise | 495 | Edison Investment Research | In September 2023, Accsys warned of weaker market conditions in the building materials and construction markets and in November, it stated not to expect trading conditions to improve materially until... ► Artikel lesen | |
22.01. | OSE Immunotherapeutics - Active year ahead for proprietary programmes | 391 | Edison Investment Research | OSE has refreshed its outlook for 2024, including the commencement of the confirmatory Phase III trial for lead asset Tedopi (an off-the-shelf, neoepitope-based cancer vaccine) in second-line non-small... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
SUPER MICRO COMPUTER | 3.925 |
EVOTEC | 3.142 |
TUI | 2.774 |
NVIDIA | 2.687 |
BAYER | 2.638 |
NEL | 2.421 |
RENK GROUP | 1.768 |
RHEINMETALL | 1.679 |
TESLA | 1.277 |
PALANTIR TECHNOLOGIES | 1.248 |
VOLKSWAGEN | 1.246 |
DEUTSCHE BANK | 1.133 |
PLUG POWER | 1.051 |
MICROSTRATEGY | 1.031 |
BYD | 1.028 |
AMAZON | 1.024 |
BASF | 1.011 |
PROSIEBENSAT.1 | 1.010 |
COMMERZBANK | 1.007 |
MERCEDES-BENZ | 931 |
THYSSENKRUPP | 927 |
ALLIANZ | 875 |
JINKOSOLAR | 871 |
DEUTSCHE TELEKOM | 866 |
AIXTRON SE | 864 |